teclistamab,talquetamab
genmab,janssen
['multiplemyeloma', 'talquetamab', 'teclistamab']
treatment with teclistamab-cqyv and talquetamab achieved encouraging responses and had a manageable safety profile in patients with relapsed or refractory #multiplemyeloma, including those with extramedullary soft tissue plasmacytomas. #eha2023 
Oncology news and insights from leading researchers and cancer centers.